Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following liver transplantation?
Safadi
R
R
Liver Unit, Hadassah University Hospital, Jerusalem, Israel.
E'id
A
A
Ilan
Y
Y
Ashur
Y
Y
Jurim
O
O
Shouval
D
D
D000328:Adult; D000914:Antibodies, Viral / Q000627:therapeutic use*; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000209:etiology; D006515:Hepatitis B virus / Q000276:immunology; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous
D000914:Antibodies, Viral